Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Operating Expenses | 7,229 | 6,393 | 6,433 | 4,594 | 3,894 |
| Operating Income | -7,229 | -6,393 | -6,433 | -4,594 | -3,894 |
| Other Income | 340 | 440 | 187 | 62 | 11 |
| Pre-tax Income | -6,890 | -5,952 | -6,246 | -4,532 | -3,883 |
| Net Income Continuous | -6,890 | -5,952 | -6,246 | -4,532 | -3,883 |
| Net Income | $-6,890 | $-5,952 | $-6,246 | $-4,532 | $-3,883 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| EBITDA(a) | $-7,178 | $-6,286 | $-6,342 | $-4,506 | $-3,806 |